Olga V. Tcherkasskaya

Array ( [id] => 9222543 [patent_doc_number] => 20140017318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT' [patent_app_type] => utility [patent_app_number] => 13/936500 [patent_app_country] => US [patent_app_date] => 2013-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5757 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13936500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9134462 [patent_doc_number] => 20130295176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'DIVIDABLE GALENICAL FORM ALLOWING MODIFIED RELEASE OF THE ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 13/916029 [patent_app_country] => US [patent_app_date] => 2013-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3598 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13916029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10265258 [patent_doc_number] => 20150150255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'Antibacterial Surfactant/Microgel Formulations, Methods of Making and Methods of Using the Same' [patent_app_type] => utility [patent_app_number] => 14/406618 [patent_app_country] => US [patent_app_date] => 2013-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9132 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14406618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9019965 [patent_doc_number] => 08529948 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-09-10 [patent_title] => 'Pharmaceutical formulation containing gelling agent' [patent_app_type] => utility [patent_app_number] => 13/905931 [patent_app_country] => US [patent_app_date] => 2013-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20213 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13905931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9245402 [patent_doc_number] => 08609683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Pharmaceutical formulation containing gelling agent' [patent_app_type] => utility [patent_app_number] => 13/905922 [patent_app_country] => US [patent_app_date] => 2013-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20210 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13905922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099161 [patent_doc_number] => 08563033 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-10-22 [patent_title] => 'Orally effective methylphenidate extended release powder and aqueous suspension product' [patent_app_type] => utility [patent_app_number] => 13/905808 [patent_app_country] => US [patent_app_date] => 2013-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18861 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13905808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9551780 [patent_doc_number] => 08758825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Sequestered antagonist formulations' [patent_app_type] => utility [patent_app_number] => 13/900044 [patent_app_country] => US [patent_app_date] => 2013-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27615 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9551780 [patent_doc_number] => 08758825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Sequestered antagonist formulations' [patent_app_type] => utility [patent_app_number] => 13/900044 [patent_app_country] => US [patent_app_date] => 2013-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27615 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9756341 [patent_doc_number] => 20140287042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'Oral Tablet Formulation Consisting Of Fixed Combination Of Rosuvastatin And Ezetimibe For Treatment Of Hyperlipidemia And Cardiovascular Diseases' [patent_app_type] => utility [patent_app_number] => 14/350905 [patent_app_country] => US [patent_app_date] => 2013-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3842 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13011635 [patent_doc_number] => 10028918 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-24 [patent_title] => Nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine and uses thereof [patent_app_type] => utility [patent_app_number] => 14/399335 [patent_app_country] => US [patent_app_date] => 2013-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11100 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9147740 [patent_doc_number] => 20130302263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'BLOCK TYPE-MODIFIED ORGANOPOLYSILOXANE, METHOD FOR USING THE ORGANOPOLYSILOXANE, COSMETIC, AND METHOD FOR PRODUCING THE ORGANOPOLYSILOXANE' [patent_app_type] => utility [patent_app_number] => 13/868235 [patent_app_country] => US [patent_app_date] => 2013-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11264 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13868235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10208464 [patent_doc_number] => 20150093454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'COMPOSITION COMPRISING ALPHA-LIPOIC ACID AND HONOKIOL FOR TREATING NEUROPATHIES' [patent_app_type] => utility [patent_app_number] => 14/395265 [patent_app_country] => US [patent_app_date] => 2013-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4741 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14395265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9160999 [patent_doc_number] => 20130309276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same' [patent_app_type] => utility [patent_app_number] => 13/858677 [patent_app_country] => US [patent_app_date] => 2013-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25604 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13858677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9139847 [patent_doc_number] => 08580303 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Gastric retained gabapentin dosage form' [patent_app_type] => utility [patent_app_number] => 13/854433 [patent_app_country] => US [patent_app_date] => 2013-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5540 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13854433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9538462 [patent_doc_number] => 20140163109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'TASTE-MASKED IBUPROPEN GRANULES' [patent_app_type] => utility [patent_app_number] => 14/239995 [patent_app_country] => US [patent_app_date] => 2013-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9636 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9895134 [patent_doc_number] => 20150050333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING OLMESARTAN MEDOXOMIL AND ROSUVASTATIN OR ITS SALT' [patent_app_type] => utility [patent_app_number] => 14/388115 [patent_app_country] => US [patent_app_date] => 2013-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8722 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8989315 [patent_doc_number] => 20130216596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'NANOCAPSULES CONTAINING MICROEMULSIONS' [patent_app_type] => utility [patent_app_number] => 13/848558 [patent_app_country] => US [patent_app_date] => 2013-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17275 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13848558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8989342 [patent_doc_number] => 20130216623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'APPARATUS AND FORMULATIONS FOR SUPRACHORIDAL DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/842218 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7676 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13842218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9054068 [patent_doc_number] => 20130251782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'TOPICAL APPLICATION OF INGENOL MEBUTATE WITH OCCLUSION' [patent_app_type] => utility [patent_app_number] => 13/839975 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9121 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13839975 [rel_patent_id] =>[rel_patent_doc_number] =>)